Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (20)

2022

  1. Meat Intake, Cooking Methods, Doneness Preferences and Risk of Gastric Adenocarcinoma in the MCC-Spain Study

    Nutrients, Vol. 14, Núm. 22

2021

  1. Dietary constituents: Relationship with breast cancer prognostic (MCC-Spain follow-up)

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 1, pp. 1-19

  2. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

  2. Association between polyphenol intake and breast cancer risk by menopausal and hormone receptor status

    Nutrients, Vol. 12, Núm. 4

  3. Fatty acid intake and breast cancer in the Spanish multicase–control study on cancer (MCC-Spain)

    European Journal of Nutrition, Vol. 59, Núm. 3, pp. 1171-1179

  4. The relation of CUN-BAE index with body mass index and waist circumference in adults aged 50 to 85 years: The MCC-Spain study

    Nutrients, Vol. 12, Núm. 4

  5. Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study

    Breast Cancer Research and Treatment, Vol. 181, Núm. 3, pp. 667-678

2019

  1. Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study

    Cancer Epidemiology, Vol. 61, pp. 79-88

  2. Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. High adherence to the Western, Prudent, and Mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study

    Gastric Cancer, Vol. 21, Núm. 3, pp. 372-382

  2. Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain

    Frontiers in Microbiology, Vol. 8, Núm. MAY

  2. Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study

    Preventive Medicine, Vol. 99, pp. 178-184

  3. Shift work and colorectal cancer risk in the MCC-Spain case–control study

    Scandinavian Journal of Work, Environment and Health, Vol. 43, Núm. 3, pp. 250-259

2016

  1. Menstrual and reproductive factors and risk of gastric and colorectal cancer in Spain

    PLoS ONE, Vol. 11, Núm. 10

  2. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

    BMC Cancer, Vol. 16, Núm. 1

2012

  1. The value of plasmatic determination of matrix metalloproteinase 9 as a diagnostic marker in prostate cancer. Closing the controversies

    EUROPEAN UROLOGY SUPPLEMENTS

2007

  1. Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study

    Lung Cancer, Vol. 55, Núm. 2, pp. 173-180

2006

  1. Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 241-248